Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.3K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.3K
Viral Structure00:56

Viral Structure

58.7K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
58.7K
Leaky Scanning02:28

Leaky Scanning

4.5K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
4.5K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

1.5K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K
Human Virome01:26

Human Virome

46
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
46
Introduction to Virus01:28

Introduction to Virus

2.9K
Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular Biology: Virus-Host Interactions and RNA Structure and Function.

Current topics in microbiology and immunology·2025
Same author

Functional RNA Elements in Alphavirus Genomes.

Current microbiology·2025
Same author

Molecular basis of RNA recombination in the 3'UTR of chikungunya virus genome.

Nucleic acids research·2024
Same author

A conserved Y-shaped RNA structure in the 3'UTR of chikungunya virus genome as a host-specialized element that modulates viral replication and evolution.

PLoS pathogens·2023
Same author

Author Correction: Global Implications of Local Unfolding Phenomena, Probed by Cysteine Reactivity in Human Frataxin.

Scientific reports·2020
Same author

RNA recombination at Chikungunya virus 3'UTR as an evolutionary mechanism that provides adaptability.

PLoS pathogens·2019

Related Experiment Video

Updated: Apr 28, 2026

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.4K

Decoding Self vs. Non-Self: Alphavirus Cap0 Recognition and Immune Evasion.

Santiago E Faraj1,2, Claudia V Filomatori1,2,3

  • 1Departamento de Química Biológica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires C1113AAD, Argentina.

Viruses
|April 27, 2026
PubMed
Summary

Alphavirus RNA uses a unique Cap0 structure, differing from host cell mRNA caps, to evade immune detection. Viruses employ strategies like 5' RNA folding to hide this cap, enabling infection.

Keywords:
IFIT1RIG-IRNAalphavirusinnate immune responsevirus–host interactions

More Related Videos

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

9.8K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.2K

Related Experiment Videos

Last Updated: Apr 28, 2026

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.4K
Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

9.8K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.2K

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Host cells distinguish self (Cap1/Cap2 mRNA) from non-self (alphavirus Cap0) RNA based on 5' cap methylation.
  • Immune sensors like RIG-I and IFIT1 recognize the alphavirus Cap0 structure, initiating antiviral responses.
  • Alphaviruses counteract these defenses through molecular strategies to ensure replication.

Purpose of the Study:

  • To review how alphavirus 5' RNA modifications impact host immune evasion.
  • To explore the interplay between viral evasion and host defense mechanisms.
  • To discuss the potential for developing novel vaccines based on virus-host interactions.

Main Methods:

  • Review of existing literature on alphavirus RNA structure and host immune responses.
  • Analysis of molecular mechanisms employed by alphaviruses to evade host sensors.
  • Discussion of the implications for vaccine development.

Main Results:

  • Alphavirus Cap0 structure serves as a molecular signature for immune recognition.
  • IFIT1 is proposed to sequester aberrant RNAs, inhibiting viral translation.
  • Alphaviruses have evolved mechanisms, such as 5' RNA folding, to hide their caps from host sensors.

Conclusions:

  • The structural difference in RNA caps is crucial for self-non-self discrimination.
  • Alphaviruses actively evade host immunity through sophisticated molecular strategies.
  • Understanding these interactions is key to developing effective antiviral vaccines.